Suppr超能文献

慢性阻塞性肺疾病全国患者样本中的合并症、患者知识与疾病管理

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.

作者信息

Barr R Graham, Celli Bartolome R, Mannino David M, Petty Thomas, Rennard Stephen I, Sciurba Frank C, Stoller James K, Thomashow Byron M, Turino Gerard M

机构信息

Division of General Medicine, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

出版信息

Am J Med. 2009 Apr;122(4):348-55. doi: 10.1016/j.amjmed.2008.09.042.

Abstract

OBJECTIVE

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States but is often undertreated. COPD often overlaps with other conditions such as hypertension and osteoporosis, which are less morbid but may be treated more aggressively. We evaluated the prevalence of these comorbid conditions and compared testing, patient knowledge, and management in a national sample of patients with COPD.

METHODS

A survey was administered by telephone in 2006 to 1003 patients with COPD to evaluate the prevalence of comorbid conditions, diagnostic testing, knowledge, and management using standardized instruments. The completion rate was 87%.

RESULTS

Among 1003 patients with COPD, 61% reported moderate or severe dyspnea and 41% reported a prior hospitalization for COPD. The most prevalent comorbid diagnoses were hypertension (55%), hypercholesterolemia (52%), depression (37%), cataracts (31%), and osteoporosis (28%). Only 10% of respondents knew their forced expiratory volume in 1 second (95% confidence interval [CI], 8-12) compared with 79% who knew their blood pressure (95% CI, 76-83). Seventy-two percent (95% CI, 69-75) reported taking any medication for COPD, usually a short-acting bronchodilator, whereas 87% (95% CI, 84-90) of patients with COPD and hypertension were taking an antihypertensive medication and 72% (95% CI, 68-75) of patients with COPD and hypercholesterolemia were taking a statin.

CONCLUSION

Although most patients with COPD in this national sample were symptomatic and many had been hospitalized for COPD, COPD self-knowledge was low and COPD was undertreated compared with generally asymptomatic, less morbid conditions such as hypertension.

摘要

目的

慢性阻塞性肺疾病(COPD)是美国第四大死因,但常常治疗不足。COPD常与其他疾病如高血压和骨质疏松症并存,这些疾病虽致死率较低,但治疗可能更为积极。我们评估了这些合并症的患病率,并比较了全国范围内COPD患者样本的检测情况、患者知识水平及治疗情况。

方法

2006年通过电话对1003例COPD患者进行了一项调查,使用标准化工具评估合并症的患病率、诊断检测、知识水平及治疗情况。完成率为87%。

结果

在1003例COPD患者中,61%报告有中度或重度呼吸困难,41%报告曾因COPD住院治疗。最常见的合并诊断为高血压(55%)、高胆固醇血症(52%)、抑郁症(37%)、白内障(31%)和骨质疏松症(28%)。只有10%的受访者知道自己的一秒用力呼气量(95%置信区间[CI],8 - 12),相比之下,79%的人知道自己的血压(95% CI,76 - 83)。72%(95% CI,69 - 75)的人报告服用过治疗COPD的药物,通常是短效支气管扩张剂,而87%(95% CI,84 - 90)的COPD合并高血压患者服用了抗高血压药物,72%(95% CI,68 - 75)的COPD合并高胆固醇血症患者服用了他汀类药物。

结论

尽管该全国样本中的大多数COPD患者有症状,且许多人曾因COPD住院,但与高血压等通常无症状、致死率较低的疾病相比,COPD患者的自我认知水平较低,且COPD治疗不足。

相似文献

1
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.
Am J Med. 2009 Apr;122(4):348-55. doi: 10.1016/j.amjmed.2008.09.042.
2
Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
Int J Chron Obstruct Pulmon Dis. 2015 Aug 7;10:1571-82. doi: 10.2147/COPD.S85767. eCollection 2015.
3
Management of COPD, equal treatment across age, gender, and social situation? A register study.
Int J Chron Obstruct Pulmon Dis. 2016 Oct 26;11:2681-2690. doi: 10.2147/COPD.S115238. eCollection 2016.
5
Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units.
Int J Chron Obstruct Pulmon Dis. 2015 Jan 22;10:173-83. doi: 10.2147/COPD.S74645. eCollection 2015.
6
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.
7
Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Int J Chron Obstruct Pulmon Dis. 2017 Feb 23;12:735-744. doi: 10.2147/COPD.S112256. eCollection 2017.
8
Prevalence of comorbidities in COPD patients by disease severity in a German population.
Respir Med. 2017 Nov;132:132-138. doi: 10.1016/j.rmed.2017.10.007. Epub 2017 Oct 12.
9
Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
Int J Chron Obstruct Pulmon Dis. 2017 Nov 13;12:3301-3310. doi: 10.2147/COPD.S145910. eCollection 2017.
10
Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
Ann Am Thorac Soc. 2019 Jun;16(6):707-714. doi: 10.1513/AnnalsATS.201809-615OC.

引用本文的文献

3
Expanding the Role of the Surgical Preoperative Evaluation Clinic: Impact on Risk and Quality Outcome Measures.
Mayo Clin Proc Innov Qual Outcomes. 2023 Sep 29;7(5):462-469. doi: 10.1016/j.mayocpiqo.2023.07.006. eCollection 2023 Oct.
4
Unraveling the Predictive Potential of Rapid Scoring in Pleural Infection: A Critical Review.
Cureus. 2023 Sep 1;15(9):e44515. doi: 10.7759/cureus.44515. eCollection 2023 Sep.
9
Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.
Int J Chron Obstruct Pulmon Dis. 2022 Sep 25;17:2401-2415. doi: 10.2147/COPD.S380736. eCollection 2022.
10
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
NPJ Prim Care Respir Med. 2022 May 26;32(1):18. doi: 10.1038/s41533-022-00282-y.

本文引用的文献

1
Complex chronic comorbidities of COPD.
Eur Respir J. 2008 Jan;31(1):204-12. doi: 10.1183/09031936.00114307.
2
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. doi: 10.1164/rccm.200707-973OC. Epub 2007 Oct 4.
3
Systemic inflammation and COPD: the Framingham Heart Study.
Chest. 2008 Jan;133(1):19-25. doi: 10.1378/chest.07-0058. Epub 2007 Oct 1.
4
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070.
5
Mortality in COPD: Role of comorbidities.
Eur Respir J. 2006 Dec;28(6):1245-57. doi: 10.1183/09031936.00133805.
7
Chronic obstructive pulmonary disease severity and cardiovascular outcomes.
Eur J Epidemiol. 2006;21(11):803-13. doi: 10.1007/s10654-006-9066-1. Epub 2006 Nov 15.
9
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
Thorax. 2006 Oct;61(10):854-62. doi: 10.1136/thx.2006.063271. Epub 2006 Jul 14.
10
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.
Respir Med. 2007 Jan;101(1):177-85. doi: 10.1016/j.rmed.2006.03.029. Epub 2006 May 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验